Earnings Call Summary | Pfizer(PFE.US) Q1 2024 Earnings Conference
The following is a summary of the Pfizer Inc. (PFE) Q1 2024 Earnings Call Transcript:Financial Performance:Pfizer reported Q1 revenue of $14.9 billion, indicating an operational decline of 19% due to
Carvana, Enovix, Pfizer, Nio, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Wednesday saw a mixed performance in major U.S. indices. The Dow Jones Industrial Average closed the day with a 0.2% increase at 37,903.29, while the S&P 500 finished lower by 0.3% at 5,018.39. Simila
GlaxoSmithKline To Go Ex-Dividend On May 16th, 2024 With 0.37619 USD Dividend Per Share
May 2nd - $GlaxoSmithKline(GSK.US)$ is trading ex-dividend on May 16th, 2024. Shareholders of record on May 17th, 2024 will receive 0.37619 USD dividend per share on July 11th, 2024. The ex-divide
Top 20 Turnover | Nvidia fell nearly 4%, with a turnover of about US$46.7 billion
On Wednesday, Nvidia, the number one in terms of US stock turnover, closed down 3.89% to US$46.699 billion; Amazon, which ranked second, closed 2.29% higher, with a transaction of US$17.064 billion; and Tesla, which ranked third, closed down 1.80%, with a transaction of US$16.85 billion.
US stocks closed | The three major indices had mixed ups and downs, ultra-microcomputers fell more than 14%, and AMD fell nearly 9%
The S&P Index closed two consecutive losses, with Nvidia falling nearly 4%; Amazon closed up more than 2% and Starbucks fell nearly 16% after the earnings report.
Why Pfizer Stock Blasted More Than 6% Higher Today
Health Care Climbs as Pfizer, GSK Rise -- Health Care Roundup
Health-care companies rose after generally strong earnings. Pfizer shares surged, rising by more than 5%, after the drug giant said sales of blood thinner Eliquis and oncology drugs offset a slide in
Jefferies Remains a Buy on Pfizer (PFE)
Pfizer Shares Jump After Beating Estimates -- WSJ
By Jared S. Hopkins Pfizer shares rose more than 6% Wednesday afternoon after the company's first-quarter results beat Wall Street analyst estimates and the drugmaker raised its earnings-per-share gu
Pfizer Options Spot-On: On May 1st, 450.87K Contracts Were Traded, With 3.3 Million Open Interest
On May 1st ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 450.87K options for the day, of which put options accounted for 36.86% of the total transactions, and call op
US Equity Markets Close Mixed Wednesday After Fed Holds Rates Steady
US equity markets ended mixed Wednesday as investors evaluated the Federal Reserve's decision to hold interest rates steady. * The Federal Open Market Committee maintained its target range for the fed
Pfizer Stock Gains 7% After Earnings Beat, Company Calls Dividend 'Secure'
Johnson & Johnson's Latest Gambit to Solve Its Massive Talcum Powder Asbestos Issue: A $6.5 Billion Settlement, Paid Out Over 25 Years
Dow Rallies Nearly 325 Points On Gains For Johnson & Johnson, Amazon.Com Inc. Shares
This article was automatically generated by MarketWatch using technology from Automated Insights. The Dow Jones Industrial Average is climbing Wednesday afternoon with shares of Johnson & Johnson and
Research Alert: CFRA Keeps Hold Opinion On Shares Of Johnson & Johnson
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: JNJ shares are up more than 4.5% intrada
Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 200 points on Wednesday. The Federal Reserve opted to keep the federal funds rate unchanged at 5.25% to 5.5%,
Trending: Pfizer 1Q Earnings Top Estimates; Raises FY24 View
14:19 ET -- Pfizer is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. The New York-based biopharmaceutical firm said first-quarte
Pfizer Up Nearly 6%, on Pace for Largest Percent Increase Since December 2021 -- Data Talk
Pfizer Inc. (PFE) is currently at $27.09, up $1.47 or 5.75% --Would be highest close since April 3, 2024, when it closed at $27.22 --On pace for largest percent increase since Dec. 15, 2021, when it
Incyte Price Target Cut to $80.00/Share From $88.00 by TD Cowen
Incyte Price Target Cut to $80.00/Share From $88.00 by TD Cowen
CVS Stresses 'Margins Over Membership' to Offset Medicare Pressure